Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights about the latest news ...
PanCAN wants every patient facing pancreatic cancer to be empowered to explore clinical trials. They are a critical treatment option in the fight against this tough disease, driving progress for ...
PanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.
PanCAN and our national grassroots community of advocates led the charge to create the first-ever Pancreatic Cancer Research Program (PCARP) at the Department of Defense (DoD) in 2019. That year, ...
The 119th Congress was sworn in on January 3, including 56 new members across both the House and Senate – all of whom need to be educated about the critical role they play in the urgent fight against ...
Today the American Cancer Society called out the need for more progress on pancreatic cancer, citing it as the third-leading cause of cancer-related death in the U.S. Their annual report also includes ...
Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...
Pranathi Perati almost cancelled the endoscopy appointment she had scheduled. Antacids seemed to be helping the abdominal discomfort she had been experiencing, but at the urging of her husband, she ...
“We do not stand on the sidelines. We are in the field, working with researchers to make real progress for patients.” As part of our strategic approach to improve outcomes for pancreatic cancer ...